Kraig Biocraft Laboratories, Inc.
KBLB· OTC
KBLBKraig Biocraft Laboratories, Inc.
Filed Nov 13, 2024 · 10-Q · 44 days after period end · 0001493152-24-045153
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Net Income | -$433.20K | -$549.27K | -$810.36K | -$3.19M |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 13, 2024 · 44 d after period end
